![Cong Xu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cong Xu
Private Equity Investor chez LAV Management Co., Ltd.
Postes actifs de Cong Xu
Sociétés | Poste | Début | Fin |
---|---|---|---|
LAV Management Co., Ltd.
![]() LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | 01/01/2018 | - |
Historique de carrière de Cong Xu
Anciens postes connus de Cong Xu
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMPACT Therapeutics, Inc.
![]() IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | President | 01/01/2018 | 01/12/2019 |
Formation de Cong Xu
University of British Columbia | Masters Business Admin |
Clemson University | Graduate Degree |
Statistiques
Internationale
Chine | 3 |
Canada | 2 |
Etats-Unis | 2 |
Opérationnelle
Private Equity Investor | 1 |
President | 1 |
Masters Business Admin | 1 |
Sectorielle
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
LAV Management Co., Ltd.
![]() LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
IMPACT Therapeutics, Inc.
![]() IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Health Technology |